BCR and synovial sarcoma: Moreover, B-cell receptor (BCR)-mediated AIDs, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Sjögren’s syndrome (SS), often result in disease progression due to uncontrolled proliferation and transformation of malignant B cells (4).